Trombose venosa profunda em idade pediátrica – estudo retrospetivo de 10 anos
Keywords:Venous thrombosis, Pulmonary Embolism, Deep Venous Thrombosis, Adolescent, Oral Contraceptives, Pediatrics
Introduction: The venous thromboembolism (VTE), an emerging disease in pediatric age, comprises deep veins thrombosis (DVT) and Pulmonary Embolism. The goal of this case series is the evaluation of the most relevant features as well as the diagnosis, treatment and prevention of DVT in children.
Methods: Descriptive retrospective review of patients’ records admitted with diagnosis of TVP in the last decade in ULSAM’s Pediatric Department.
Results: The study population consisted of six patients, five of whom were female. The median age was 17 years old. The edema was the most frequent symptom and the ileo-femoral venous segment the most affected (2/6). There were at least two concomitant acquired risk factors in three patients, the most common of which being combinated oral contraceptive. There were five patients without thrombophilia, but we are waiting the last patient results. The mean treatment duration was 9,8 months.
Discussion and Conclusion: TVP is a relatively rare event in childhood, but, when present, causes significant morbidity and mortality. As reported in literature, the highest incidence of DVT was documented in adolescents with lower limb impairment. We found a conjunction of several risk factors that are likely to potentiate each other, leading to the occurrence of VTE. It is possible that the pediatrician is facing with a new, previously excluded, pathology of pediatric care. Besides, the incidence’s increase of this condition may suggest that the use of oral contraceptives by teenage females rises the thrombotic risk. It is important to create a national consensus on the approach and prevention of this illness in pediatric age.
Boulet SL, Grosse SD, Thornburg CD, Yusuf H, Tsai J, Hooper WC. Trends in venous thromboembolism-related hospitalization, 1994-2009. Pediatrics 2012; 130: 812-20.
Spentzouris G, Scriven RJ, Lee TK, Labropoulos N, Brook
S. Pediatric venous thromboembolism in relation to adults. J Vasc Surg 2012; 55: 1785-93.
Carvalho J, Almeida N, Santos JF, Pico Rivera. Trombofilia hereditária. Rastreio: fazer ou não? Acta Pediatr Port 2013; 44(5): 253-6.
Albisetti M, Chan AKC. Pathogenesis and clinical manifestations of venous thrombosis and thromboembolism in infants and children. UpToDate® 2015; 1-11.
Loureiro CC, Rezende T. Tromboembolismo venoso aos 6 anos. Acta Pediatr Port 2007; 38(6): 265-7.
Chan AKC, Monagle P. Updates in thrombosis in pediatrics: where are we after 20 years? Hematol 2012; 439-43.
Zöller B, Li X, Sundquist J, Sundquist K, Crump C. Gestacional age and risk of venous thromboembolism from birth through young adulthood. Pediatrics 2014; 134: 473-80.
Santos ME, Júnior BJN, Correia MCB, Lima VLM, Abib SCV, Coelho LCBB. Trombose venosa em criança. Bras Patol Med Lab 2009; v. 45, nº 3: 201-5.
Silva AS, Brazão ML, Granito S, Escórcio S, Jardim M, Silva S, et al. Distúrbios pró-trombóticos/Trombofilias. Rev Soc. Port Med Int 2010; Vol. 17, nº 1: 49-64.
Fonseca AG, Amaro M. Trombofilias: importância do seu estudo na patologia tromboembólica. Rev Soc Port Med Int 2008; 15 (4): 284-90.
Raffini L. Thrombophilia in Children: Who to test, how, when, and why? Hematol 2008; 228-35.
Howard SC. Pediatric Thromboembolism. Medscape 2014; 1-7.
Lobo RA, Romão F. Hormonas sexuais femininas e trombose venosa profunda. Ang e Cir Vasc 2011; 7 (4): 1-7.
Pacheco A, Machado AI, Costa AR, Lanhoso A, Cruz E, Palma F et al. Contracepção Hormonal Combinada. In: Consenso Sobre Contracepção 2011; Estoril, 5 de janeiro de 2011. Edições Frist News®; p. 9-23.
Albisetti M, Chan AKC. Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children. UpToDate® 2015; 1-18.
Lip GYH, Hull RD. Overview of the treatment of lower extremity deep vein thrombosis. UpToDate® 2015; 1-26.
Maffei FHA, Winston BY, Lastória S. Tromboembolismo venoso em crianças e adolescentes. J Vasc Br 2002; 1 (2):121-28.
How to Cite
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.